Skip to content
10-Q

Quarterly Report

PURE Bioscience, Inc. PURE

0001493152-25-027749

← back to feed
Filed
Dec 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Dec 15, 2025 111.89M sh
Shares Diluted Q1 2026 · Oct 31, 2025 111.89M sh
Shares Diluted Q1 2026 · Oct 31, 2024 111.86M sh
Operating Cash Flow Q1 2026 · Oct 31, 2025 −$250K
Operating Cash Flow Q1 2026 · Oct 31, 2024 −$503K
Cash And Equivalents Q1 2026 · Oct 31, 2025 $434K
Cash And Equivalents Q1 2026 · Jul 31, 2025 $334K
Cash And Equivalents Q1 2026 · Oct 31, 2024 $346K
Stockholders Equity Q1 2026 · Oct 31, 2025 −$5.55M
Stockholders Equity Q1 2026 · Jul 31, 2025 −$5.12M
Stockholders Equity Q1 2026 · Oct 31, 2024 −$3.5M
Stockholders Equity Q1 2026 · Jul 31, 2024 −$2.86M
Current Liabilities Q1 2026 · Oct 31, 2025 $3.16M
Current Liabilities Q1 2026 · Jul 31, 2025 $938K
Total Liabilities Q1 2026 · Oct 31, 2025 $6.73M
Total Liabilities Q1 2026 · Jul 31, 2025 $6.17M
Current Assets Q1 2026 · Oct 31, 2025 $1.18M
Current Assets Q1 2026 · Jul 31, 2025 $1.05M
Total Assets Q1 2026 · Oct 31, 2025 $1.19M
Total Assets Q1 2026 · Jul 31, 2025 $1.06M
Eps Diluted Q1 2026 · Oct 31, 2025 $0.00
Eps Diluted Q1 2026 · Oct 31, 2024 −$0.01
Eps Basic Q1 2026 · Oct 31, 2025 $0.00
Eps Basic Q1 2026 · Oct 31, 2024 −$0.01
Sga Expense Q1 2026 · Oct 31, 2025 $743K
Sga Expense Q1 2026 · Oct 31, 2024 $881K
Rd Expense Q1 2026 · Oct 31, 2025 $86K
Rd Expense Q1 2026 · Oct 31, 2024 $71K
Net Income Q1 2026 · Oct 31, 2025 −$464K
Net Income Q1 2026 · Oct 31, 2024 −$689K
Operating Income Q1 2026 · Oct 31, 2025 −$379K
Operating Income Q1 2026 · Oct 31, 2024 −$627K
Gross Profit Q1 2026 · Oct 31, 2025 $450K
Gross Profit Q1 2026 · Oct 31, 2024 $325K
Cost Of Revenue Q1 2026 · Oct 31, 2025 $258K
Cost Of Revenue Q1 2026 · Oct 31, 2024 $231K
Revenue Q1 2026 · Oct 31, 2025 $708K
Revenue Q1 2026 · Oct 31, 2024 $556K